Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

French team designs novel antiangiogenic agents

Aug. 28, 2012

Novel beta1-adrenoceptor ligands developed in U.K.

Aug. 27, 2012

Collaborating organizations in France design new candidate drugs for parasitic diseases

Aug. 27, 2012

Novartis reports new mTOR/PI3K inhibitors

Aug. 27, 2012

New inhibitors of V600E-mutant B-raf presented

Aug. 27, 2012

Research at U.S. university yields new MAT 2 inhibitors

Aug. 24, 2012

New antifungals designed in Japan

Aug. 24, 2012

Sato Pharmaceutical designs new urate anion exchanger inhibitors

Aug. 24, 2012

Investigators extract new HMG-CoA reductase inhibitors from yeast

Aug. 24, 2012

New PDE2A/10A inhibitors reported

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...